Ultralife (NASDAQ:ULBI – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Thursday, February 20th. Analysts expect the company to announce earnings of $0.23 per share and revenue of $40.00 million for the quarter.
Ultralife Stock Down 2.7 %
ULBI opened at $7.25 on Thursday. The company has a 50 day moving average of $7.61 and a 200 day moving average of $8.67. The company has a current ratio of 3.30, a quick ratio of 1.62 and a debt-to-equity ratio of 0.04. Ultralife has a 12 month low of $7.02 and a 12 month high of $13.39. The company has a market cap of $120.57 million, a PE ratio of 13.18 and a beta of 0.96.
Analyst Upgrades and Downgrades
Separately, Benchmark reissued a “buy” rating and set a $14.00 price objective on shares of Ultralife in a report on Friday, November 15th.
About Ultralife
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Featured Stories
- Five stocks we like better than Ultralife
- Canada Bond Market Holiday: How to Invest and Trade
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.